EPIGRAL LIMITED Valuation
EPIGRAL · Chemicals · Current price ₹1,231.9
Is EPIGRAL LIMITED undervalued?
DocStoX estimates the fair value of EPIGRAL LIMITED at ₹1,416 per share, versus the current market price of ₹1,232. That puts the stock about +15.0% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹573), Relative P/E (₹3,490), Graham floor (₹946), Analyst target (₹1,456). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹573 (bear) to ₹1,416 (base) to ₹3,490 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
EPIGRAL LIMITED trades at a P/E of 16.0x and a P/B of 2.4x, with a dividend yield of 0.4%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on EPIGRAL LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.